.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Fuji
US Department of Justice
Chubb
Mallinckrodt
McKesson
Express Scripts
Julphar
Colorcon
Harvard Business School

Generated: September 19, 2017

DrugPatentWatch Database Preview

Famciclovir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for famciclovir and what is the scope of famciclovir freedom to operate?

Famciclovir
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Macleods Pharms Ltd, West-ward Pharms Int, Mylan, Hetero Labs Ltd V, Novartis, Cipla Ltd, Apotex, and Teva Pharms, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for famciclovir. Nineteen suppliers are listed for this compound.

Summary for Generic Name: famciclovir

Tradenames:2
Patents:0
Applicants:9
NDAs:9
Drug Master File Entries: see list8
Suppliers / Packagers: see list19
Bulk Api Vendors: see list77
Clinical Trials: see list19
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:famciclovir at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
FAMCICLOVIR
famciclovir
TABLET;ORAL201333-002Mar 24, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
FAMCICLOVIR
famciclovir
TABLET;ORAL091114-002Mar 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
FAMCICLOVIR
famciclovir
TABLET;ORAL078278-003Mar 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
FAMCICLOVIR
famciclovir
TABLET;ORAL202438-002Sep 10, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
FAMCICLOVIR
famciclovir
TABLET;ORAL078278-002Mar 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
FAMCICLOVIR
famciclovir
TABLET;ORAL077487-001Aug 24, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
FAMCICLOVIR
famciclovir
TABLET;ORAL201333-003Mar 24, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
FAMCICLOVIR
famciclovir
TABLET;ORAL078278-001Mar 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: famciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Novartis
Johnson and Johnson
Harvard Business School
Chubb
Boehringer Ingelheim
Accenture
Deloitte
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot